4.6 Article

Decreased phosphatidylcholine plasmalogens - A putative novel lipid signature in patients with stable coronary artery disease and acute myocardial infarction

Journal

ATHEROSCLEROSIS
Volume 246, Issue -, Pages 130-140

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.atherosclerosis.2016.01.003

Keywords

Glycerophospholipids; Sphingolipids; Coronary artery disease; Acute myocardial infarction

Funding

  1. Zurich Center of Integrated Human Physiology, University of Zurich (ZIHP)
  2. Foundation for Pathobiochemistry and Molecular Diagnostics of the German Society for Clinical Chemistry and Laboratory Medicine
  3. Swiss National Science Foundation [SPUM 33CM30-124112]
  4. Swiss Heart Foundation
  5. Fondation Leducq
  6. Foundation for Cardiovascular Research, Zurich
  7. Roche
  8. Eli Lilly (USA)
  9. AstraZeneca (Switzerland)
  10. Medtronic (Switzerland)
  11. MSD (Switzerland)
  12. Sanofi (Switzerland)
  13. St. Jude Medical (Switzerland)

Ask authors/readers for more resources

Objective: Glycerophospholipids and sphingolipids are structurally heterogeneous due to differences in the O-and N-linked fatty acids and head groups. Sphingolipids also show a heterogeneity in their sphingoid base composition which up to now has been little appreciated. The aim of this study was to investigate the association of certain glycerophospholipid and sphingolipid species with stable coronary artery disease (CAD) and acute myocardial infarction (AMI). Methods: The lipid profile in plasma from patients with stable CAD (n = 18) or AMI (n = 17) was compared to healthy subjects (n = 14). Sixty five glycerophospholipid and sphingolipid species were quantified by LC-MS. The relative distribution of these lipids into lipoprotein fractions was analyzed. Results: In the CAD cohort, 45 glycerophospholipid and sphingolipid species were significantly lower compared to healthy controls. In the AMI group, 42 glycerophospholipid and sphingolipid species were reduced. Four PC plasmalogens (PC33: 1, PC33: 2, PC33: 3 and PC35: 3) showed the most significant difference. Out of eleven analyzed sphingoid bases, four were lower in the CAD and six in the AMI group. Sphingosine-1-phosphate (S1P) levels were reduced in the AMI group whereas an atypical C16: 1 S1P was lower in both groups. Phosphatidylcholine and sphingomyelin species were exclusively present in lipoprotein particles, whereas lysophosphatidylcholines were mainly found in the lipoprotein-free fraction. The observed differences were not explained by the use of statins as confirmed in a second, independent cohort. Conclusions: Reduced levels of four PC plasmalogens (PC33: 1, PC33: 2, PC33: 3 and PC35: 3) were identified as a putatively novel lipid signature for CAD and AMI. (C) 2016 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Geriatrics & Gerontology

The effect of thyroid hormone therapy on muscle function, strength and mass in older adults with subclinical hypothyroidism-an ancillary study within two randomized placebo controlled trials

Seraina Netzer, Patricia Chocano-Bedoya, Martin Feller, Camilla Janett-Pellegri, Lea Wildisen, Annina E. Buchi, Elisavet Moutzouri, Elena Gonzalez Rodriguez, Tinh-Hai Collet, Rosalinde K. E. Poortvliet, Vera J. C. Mc Carthy, Daniel Aeberli, Drahomir Aujesky, Rudi Westendorp, Terence J. Quinn, Jacobijn Gussekloo, Patricia M. Kearney, Simon Mooijaart, Douglas C. Bauer, Nicolas Rodondi

Summary: The loss of skeletal muscle function, strength, and mass is common in older adults, and it has significant socioeconomic impact. Subclinical hypothyroidism, which is prevalent in older adults, has been associated with reduced muscle strength. However, there hasn't been a randomized placebo-controlled trial to investigate the effect of treating subclinical hypothyroidism on muscle function and mass.

AGE AND AGEING (2023)

Article Hematology

Thrombophilia and outcomes of venous thromboembolism in older patients

Marie Mean, Neal Breakey, Odile Stalder, Lorenzo Alberio, Andreas Limacher, Anne Angelillo-Scherrer, Pierre Fontana, Hans Jurg Beer, Nicolas Rodondi, Drahomir Aujesky, Bernhard Laemmle, Robert Escher

Summary: This study examined the prevalence of laboratory thrombophilic risk factors in elderly patients with VTE and their association with clinical outcomes. The results showed that 78% of patients had at least one risk factor, with elevated levels of various factors being the most common. The study also found significant associations between certain risk factors and VTE recurrence and death.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2023)

Article Oncology

ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma

Ossia M. Eichhoff, Corinne I. Stoffel, Jan Kasler, Luzia Briker, Patrick Turko, Gergely Karsai, Nina Zila, Verena Paulitschke, Phil F. Cheng, Alexander Leitner, Andrea Bileck, Nicola Zamboni, Anja Irmisch, Zsolt Balazs, Aizhan Tastanova, Susana Pascoal, Pal Johansen, Rebekka Wegmann, Julien Mena, Alaa Othman, Vasanthi S. Viswanathan, Judith Wenzina, Andrea Aloia, Annalisa Saltari, Andreas Dzung, Michael Krauthammer, Stuart L. Schreiber, Thorsten Hornemann, Martin Distel, Berend Snijder, Reinhard Dummer, Mitchell P. Levesque

Summary: The clinical management of NRAS-mutated melanomas is challenging due to resistance that arises through genetic, transcriptional, and metabolic adaptation. However, the adoption of a mesenchymal phenotype with a quiescent metabolic program in NRAS-mutated melanoma cells confers sensitivity to reactive oxygen species (ROS) induction, which can be inhibited by ROS inducers in combination with MAPK pathway inhibitors. The findings suggest that targeting both metabolic reprogramming and MAPK signaling could improve patient treatment in melanoma and other cancers.

CANCER RESEARCH (2023)

Article Cardiac & Cardiovascular Systems

Clinical Outcomes in High-Gradient, Classical Low-Flow, Low-Gradient, and Paradoxical Low-Flow, Low-Gradient Aortic Stenosis After Transcatheter Aortic Valve Implantation: A Report From the SwissTAVI Registry

Max Wagener, Oliver Reuthebuch, Dik Heg, David Tuller, Enrico Ferrari, Jurg Grunenfelder, Christoph Huber, Igal Moarof, Olivier Muller, Fabian Nietlispach, Stephane Noble, Marco Roffi, Maurizio Taramasso, Christian Templin, Stefan Toggweiler, Peter Wenaweser, Stephan Windecker, Stefan Stortecky, Raban Jeger

Summary: This study compares the mortality rates of different types of severe aortic stenosis (high-gradient, classical low-flow low-gradient, and paradoxical low-flow low-gradient) after transcatheter aortic valve implantation. The results show that patients with paradoxical low-flow low-gradient aortic stenosis have lower mortality rates than patients with classical low-flow low-gradient, but higher mortality rates than those with high-gradient.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Article Cardiac & Cardiovascular Systems

Omega-3 Fatty Acids and Heart Rhythm, Rate, and Variability in Atrial Fibrillation

Philipp F. Baumgartner, Martin Reiner, Andrea Wiencierz, Michael R. Coslovsky, Nicole G. Bonetti, Mark Filipovic, Stefanie Aeschbacher, Michael S. Kuhne, Christine Zuern, Nicolas Rodondi, Jolanda Oberle, Giorgio F. Moschovitis, Thomas G. Luscher, Giovanni Camici, Stefan Osswald, David Conen, Jurg H. Beer

Summary: This study found no strong evidence for an association between n-3 FA blood levels and AF type, but higher total n-3 FA levels and docosahexaenoic acid may be correlated with lower heart rate, and docosapentaenoic acid with lower heart rate variability triangular index.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Article Endocrinology & Metabolism

Basal re-esterification finetunes mitochondrial fatty acid utilization

Anand Kumar Sharma, Tongtong Wang, Alaa Othman, Radhika Khandelwal, Miroslav Balaz, Salvatore Modica, Nicola Zamboni, Christian Wolfrum

Summary: Emerging evidence suggests the existence of constant basal lipolysis and re-esterification of fatty acids. In this study, the role of lipolysis coupled to re-esterification under basal conditions was investigated. The results showed that DGAT1 and DGAT2 mediated re-esterification plays a role in regulating fatty acid oxidation and mitochondrial fuel utilization.

MOLECULAR METABOLISM (2023)

Article Biochemistry & Molecular Biology

Altered Distribution of Unesterified Cholesterol among Lipoprotein Subfractions of Patients with Diabetes Mellitus Type 2

Livia Noemi Kolb, Alaa Othman, Lucia Rohrer, Jan Kruetzfeldt, Arnold von Eckardstein

Summary: Biomarkers are important for early detection and stratification of diabetes and its complications. In this study, we used NMR spectrometry to analyze metabolic parameters in plasma samples of healthy volunteers and diabetic patients. Our results showed independent associations between diabetes and branched-chain amino acids, lactate, linoleic acid, and HDL diameter. Additionally, we found imbalances in the concentrations of free cholesterol in different lipoprotein subclasses in diabetic subjects compared to non-diabetic controls, which may reflect disturbances in cholesterol transfer processes.

BIOMOLECULES (2023)

Article Cardiac & Cardiovascular Systems

Clinical outcomes in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary interventions later than 48 h after symptom onset

Miklos Rohla, Fabrice Temperli, George C. M. Siontis, Roland Klingenberg, Baris Gencer, Nicolas Rodondi, Sarah Bar, David Nanchen, Francois Mach, Jonas D. Haner, Thomas Pilgrim, Olivier Muller, Christian M. Matter, Thomas Luscher, Marco Roffi, Dik Heg, Stephan Windecker, Lorenz Raber

Summary: This study compared the outcomes of STEMI patients undergoing PCI according to total ischemic time. The results showed that PCI performed within 12 hours of symptom onset had better outcomes, while PCI performed later than 12 hours was associated with higher mortality and target lesion failure rates. However, there was no significant difference in outcomes between PCI performed later than 48 hours and PCI performed between 12-48 hours.

EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2023)

Article Endocrinology & Metabolism

Incidence and Determinants of Spontaneous Normalization of Subclinical Hypothyroidism in Older Adults

Evie van der Spoel, Nicolien A. van Vliet, Rosalinde K. E. Poortvliet, Robert S. Du Puy, Wendy P. J. den Elzen, Terence J. Quinn, David J. Stott, Naveed Sattar, Patricia M. Kearney, Manuel R. Blum, Heba Alwan, Nicolas Rodondi, Tinh-Hai Collet, Rudi G. J. Westendorp, Bart E. Ballieux, J. Wouter Jukema, Olaf M. Dekkers, Jacobijn Gussekloo, Simon P. Mooijaart, Diana van Heemst

Summary: This study aims to investigate the incidence and determinants of spontaneous normalization of TSH levels in older adults with subclinical hypothyroidism. The study found that younger age, female sex, lower initial TSH level, higher initial free T4 level, absence of thyroid peroxidase antibodies, and a follow-up measurement in summer were independent determinants for TSH level normalization.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Article Clinical Neurology

Biomarker, Imaging, and Clinical Factors Associated With Overt and Covert Stroke in Patients With Atrial Fibrillation

Gian Marco De Marchis, Philipp Krisai, Laura Werlen, Tim Sinnecker, Stefanie Aeschbacher, Tolga D. Dittrich, Alexandros A. Polymeris, Michael Coslovksy, Manuel R. Blum, Nicolas Rodondi, Tobias Reichlin, Giorgio Moschovitis, Jens Wuerfel, Philippe A. Lyrer, Urs Fischer, David Conen, Peter Kastner, Andre Ziegler, Stefan Osswald, Michael Kuehne, Leo H. Bonati

Summary: In patients with atrial fibrillation, a model incorporating white matter lesion volume on baseline MRI and selected blood markers yielded new insights on residual stroke risk despite a high proportion of patients on oral anticoagulants. This may be relevant to develop further preventive measures.

STROKE (2023)

Article Engineering, Biomedical

Formation and Investigation of Cell-Derived Nanovesicles as Potential Therapeutics against Chronic Liver Disease

Aymar Abel Ganguin, Ivo Skorup, Sebastian Streb, Alaa Othman, Paola Luciani

Summary: This study introduces a new therapeutic approach using cell-derived nanovesicles (cdNVs) to address the lack of effective treatments for liver fibrosis. The cdNVs from LX-2 cells exhibit concentration-dependent fibrosis regression, linked to their biomolecular corona. This makes cdNVs a promising candidate for the development of liver fibrosis resolving therapeutics.

ADVANCED HEALTHCARE MATERIALS (2023)

Article Cardiac & Cardiovascular Systems

Amyloid Transthyretin Cardiomyopathy in Elderly Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation

Stephan Dobner, Thomas Pilgrim, Daniel Hagemeyer, Dik Heg, Jonas Lanz, Nicole Reusser, Christoph Graeni, Ali Afshar-Oromieh, Axel Rominger, Bettina Langhammer, David Reineke, Stephan Windecker, Stefan Stortecky

Summary: This study aims to determine the prevalence of ATTR-CM in elderly patients with severe aortic stenosis and evaluate the differences in clinical presentation and outcomes of patients with concomitant ATTR-CM undergoing transcatheter aortic valve implantation. The results showed that ATTR-CM was observed in 10.8% of patients with severe aortic stenosis, and elderly age, male sex, and prior carpal tunnel surgery were associated with the coexistence of ATTR-CM. However, there were no significant differences in peri-interventional risk and one-year clinical outcomes between patients with concomitant pathologies.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Article Physiology

Hepatocyte ABCA1 deficiency is associated with reduced HDL sphingolipids

Alaa Othman, Mingxia Liu, Heiko Bode, Elena Boudyguina, Arnold von Eckardstein, John S. Parks, Thorsten Hornemann

Summary: ATP binding cassette transporter A1 (ABCA1) limits the formation of high density lipoproteins (HDL), and the loss of ABCA1 function leads to severe deficiency of HDL in Tangier disease patients. Hepatocyte-specific knockout of ABCA1 in mice (Abca1 HSKO) significantly reduces plasma HDL-cholesterol levels, indicating that hepatic ABCA1 plays a major role in the HDL phenotype. The impact of Tangier disease on plasma sphingolipid levels and the contribution of hepatic ABCA1 to plasma sphingolipids are still unknown.

FRONTIERS IN PHYSIOLOGY (2023)

Article Medicine, General & Internal

Effect of high-dose glucocorticoid treatment on human brown adipose tissue activity: a randomised, double-blinded, placebo-controlled cross-over trial in healthy men

Claudia Irene Maushart, Wenfei Sun, Alaa Othman, Adhideb Ghosh, Jael Rut Senn, Jonas Gabriel William Fischer, Philipp Madoerin, Rahel Catherina Loeliger, Robyn Melanie Benz, Martin Takes, Christoph Johannes Zech, Alin Chirindel, Felix Beuschlein, Martin Reincke, Damian Wild, Oliver Bieri, Nicola Zamboni, Christian Wolfrum, Matthias Johannes Betz

Summary: This study found that glucocorticoids affect energy expenditure in healthy men, but do not affect the activity of brown adipose tissue that generates heat in response to cold stimulation.

EBIOMEDICINE (2023)

Article Substance Abuse

Smoking Cessation in People With and Without Diabetes After Acute Coronary Syndrome

Ludivine Clement, Baris Gencer, Olivier Muller, Roland Klingenberg, Lorenz Raeber, Christian M. Matter, Thomas F. Luescher, Stephan Windecker, Francois Mach, Nicolas Rodondi, David Nanchen, Carole Clair

Summary: Patients with diabetes have lower smoking cessation rates after acute coronary syndrome compared to those without diabetes, highlighting the importance of tailored secondary prevention programs. Cardiac rehabilitation may play a positive role in increasing smoking cessation rates.

NICOTINE & TOBACCO RESEARCH (2023)

No Data Available